As a part of the Premarket Tobacco Product Application process, Juul Labs has built up its science and evidence-based capabilities with a comprehensive research program focused on examining the public health impact of JUUL System. Juul Labs today announced findings from its science and research program at the 3rd Scientific Summit on Tobacco Harm Reduction, which was held virtually. The studies presented covered a wide range of topics that contribute to the growing body of scientific evidence on ENDS products, including information on the nicotine delivery profile of the JUUL System compared to cigarettes as well as rates of complete switching to the JUUL System among adult smokers.
Below is the full list of studies presented by Juul Labs:
In addition to the six posters Juul Labs presented, two independent contract research organizations presented studies sponsored by Juul Labs:
Juul Labs is fully committed to the Premarket Tobacco Product Application process in the United States, and to that end has built a robust scientific research program to help assess the harm-reduction potential of JUUL products, including their impact on the individual user, their ability to move adult smokers away from combustible cigarettes, and the net-population impact on public health.
The Company is committed to working cooperatively with regulators, public health officials, and other stakeholders to preserve the historic opportunity to transition adult smokers away from combustible cigarettes, while combating underage use.
Juul Labs will continue to share results from its science and research program transparently with the public health communities as it works to support the scientific basis for the category, as well as future regulatory filings.